Moshe Giladi

Insider Reports History

Location
Sh'ar Hacarmel, Haifa, Israel
Signature
Steven Robbins, as attorney in fact for Giladi, Moshe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Moshe Giladi:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Science Officer Stock Options (Right to buy) 78,174 $1,274,236 $16.30 27 Feb 2024 Direct
NovoCure Ltd Chief Science Officer Ordinary Shares 69,771 $1,137,267 $16.30 27 Feb 2024 Direct
NovoCure Ltd Chief Science Officer Restricted Share Units 353 26 Jul 2023 Direct

Insider Reports Filed by Moshe Giladi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 27 Feb 2024 2 +$2,107,557 4 Chief Science Officer 29 Feb 2024, 16:33
NVCR NovoCure Ltd 26 Jul 2023 0 $0 3 Chief Science Officer 20 Dec 2023, 16:23